METHYLNALTREXONE BROMIDE

METHYLNALTREXONE BROMIDE was reported 1520 times

METHYLNALTREXONE BROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STEROID ACTIVITY 2 0.2222
1 BURGLARY VICTIM 1 0.0909
2 HEPATIC PERFUSION DISORDER 1 0.0476
3 COLPOCELE 1 0.0370
4 HEPATIC ARTERY OCCLUSION 3 0.0353
5 JUVENILE MYOCLONIC EPILEPSY 2 0.0317
6 ACTIVATED PROTEIN C RESISTANCE 1 0.0303
7 CONCOMITANT DRUG EFFECT DECREASED 1 0.0233
8 IMPLANT SITE DEHISCENCE 2 0.0233
9 SPLENIC GRANULOMA 2 0.0187
10 HYPOGONADISM MALE 3 0.0129
11 NARCOTIC BOWEL SYNDROME 2 0.0127
12 BLOOD PRESSURE ORTHOSTATIC 2 0.0126
13 DRUG EFFECT PROLONGED 6 0.0109
14 COLON GANGRENE 1 0.0108
15 BIOPSY BONE 1 0.0085
16 HEPATIC INFARCTION 3 0.0080
17 SPINAL CORD INJURY CERVICAL 2 0.0079
18 URINARY BLADDER RUPTURE 2 0.0079
19 PERITONEAL ADHESIONS 2 0.0079
20 GASTROINTESTINAL MUCOSAL EXFOLIATION 1 0.0075
21 BREATH SOUNDS 1 0.0073
22 HYPERACTIVE PHARYNGEAL REFLEX 1 0.0069
23 GASTROENTERITIS RADIATION 2 0.0061
24 CERVIX CANCER METASTATIC 1 0.0061
25 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
26 FAECAL VOMITING 3 0.0056
27 NASAL TURBINATE HYPERTROPHY 2 0.0053
28 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 2 0.0053
29 IMPAIRED REASONING 2 0.0052
30 BREATH HOLDING 2 0.0052
31 FAECAL VOLUME DECREASED 2 0.0042
32 ACCIDENT AT HOME 2 0.0039
33 FAECAL VOLUME INCREASED 2 0.0038
34 GRIMACING 3 0.0038
35 PRESBYOPIA 2 0.0036
36 DUODENOGASTRIC REFLUX 1 0.0036
37 MEDICAL DEVICE SITE PAIN 2 0.0036
38 ANTICOAGULANT THERAPY 1 0.0035
39 ABDOMINAL WALL DISORDER 1 0.0034
40 GASTROINTESTINAL BACTERIAL OVERGROWTH 2 0.0033
41 BRONCHIAL HAEMORRHAGE 1 0.0032
42 SLEEP-RELATED EATING DISORDER 3 0.0032
43 DEVICE BATTERY ISSUE 2 0.0030
44 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 2 0.0030
45 GASTROENTERITIS BACTERIAL 1 0.0030
46 CENTRAL NERVOUS SYSTEM INFLAMMATION 1 0.0030
47 THROAT LESION 2 0.0029
48 GRANULOMATOUS LIVER DISEASE 2 0.0028
49 PRODUCT DESIGN ISSUE 2 0.0028
50 BACTERIAL DISEASE CARRIER 2 0.0027
51 ACETABULUM FRACTURE 1 0.0027
52 CHOROIDITIS 1 0.0027
53 PATIENT DISSATISFACTION WITH TREATMENT 5 0.0026
54 BLADDER PERFORATION 1 0.0026
55 VOLVULUS 6 0.0025
56 STERNAL FRACTURE 3 0.0024
57 RECTAL TENESMUS 3 0.0024
58 REBOUND ACID HYPERSECRETION 7 0.0023
59 ABDOMINAL RIGIDITY 6 0.0022
60 BODY MASS INDEX DECREASED 1 0.0022
61 GALLBLADDER RUPTURE 1 0.0022
62 TONGUE INJURY 2 0.0021
63 INTUSSUSCEPTION 2 0.0021
64 SEBORRHOEIC KERATOSIS 3 0.0021
65 GENITAL ERYTHEMA 1 0.0020
66 INFREQUENT BOWEL MOVEMENTS 5 0.0020
67 BRAIN NEOPLASM BENIGN 1 0.0020
68 SUBILEUS 4 0.0019
69 INABILITY TO AFFORD MEDICATION 19 0.0019
70 OSTEOSCLEROSIS 3 0.0019
71 HYPOPERFUSION 2 0.0019
72 POST PROCEDURAL SWELLING 2 0.0018
73 ARTERIAL HAEMORRHAGE 2 0.0017
74 LUMBAR RADICULOPATHY 2 0.0017
75 HOSPICE CARE 17 0.0017
76 DEVICE MAINTENANCE ISSUE 1 0.0017
77 COLON CANCER STAGE IV 1 0.0017
78 FAECALOMA 9 0.0016
79 PNEUMOPERITONEUM 3 0.0016
80 VICTIM OF CRIME 2 0.0016
81 POSTOPERATIVE WOUND COMPLICATION 2 0.0016
82 BLOOD PRESSURE MEASUREMENT 1 0.0016
83 JOINT CREPITATION 3 0.0015
84 DEFAECATION DISORDER 1 0.0015
85 EFFUSION 2 0.0015
86 INFUSION SITE RASH 2 0.0015
87 GENITAL SWELLING 1 0.0014
88 BOWEL MOVEMENT IRREGULARITY 11 0.0014
89 FUNGAL OESOPHAGITIS 1 0.0014
90 CATAPLEXY 2 0.0014
91 PARAPLEGIA 4 0.0014
92 LARGE INTESTINAL OBSTRUCTION 3 0.0013
93 EXPOSURE TO COMMUNICABLE DISEASE 1 0.0013
94 ADHESION 2 0.0013
95 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
96 LARGE INTESTINE PERFORATION 9 0.0013
97 EXTRADURAL ABSCESS 1 0.0013
98 BRONCHIAL CARCINOMA 1 0.0013
99 DEVICE DAMAGE 1 0.0013
100 SEBORRHOEIC DERMATITIS 2 0.0012
101 GASTRIC DILATATION 2 0.0012
102 TYMPANIC MEMBRANE PERFORATION 2 0.0012
103 INSURANCE ISSUE 18 0.0012
104 HEPATIC CANCER METASTATIC 1 0.0012
105 INJECTION SITE OEDEMA 2 0.0012
106 DRUG TITRATION ERROR 3 0.0012
107 INTESTINAL PERFORATION 13 0.0012
108 MEDICAL DEVICE REMOVAL 2 0.0012
109 HEPATIC LESION 5 0.0012
110 GASTROINTESTINAL NEOPLASM 1 0.0012
111 SPONDYLOLISTHESIS 2 0.0012
112 SPLENIC INFARCTION 2 0.0011
113 YAWNING 3 0.0011
114 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
115 CATHETER MANAGEMENT 1 0.0011
116 BONE LESION 4 0.0011
117 CLONUS 3 0.0011
118 METASTATIC RENAL CELL CARCINOMA 2 0.0011
119 CATHETER SITE SWELLING 1 0.0011
120 NASAL OBSTRUCTION 2 0.0011
121 NARCOLEPSY 2 0.0011
122 HEPATIC CONGESTION 1 0.0011
123 DRUG DISPENSED TO WRONG PATIENT 1 0.0010
124 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
125 BLOOD URINE 1 0.0010
126 ANAL CANCER 1 0.0010
127 FAECES HARD 4 0.0010
128 PULMONARY PAIN 3 0.0010
129 CONCOMITANT DISEASE PROGRESSION 2 0.0010
130 NASAL SEPTUM DEVIATION 2 0.0010
131 DUODENAL PERFORATION 1 0.0010
132 DEVICE SAFETY FEATURE ISSUE 1 0.0010
133 GASTRECTOMY 1 0.0010
134 INTRACRANIAL ANEURYSM 4 0.0010
135 HYPOGONADISM 1 0.0010
136 DYSCHEZIA 3 0.0010
137 OSTEOLYSIS 2 0.0010
138 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
139 IMPLANT SITE ERYTHEMA 1 0.0010
140 AXILLARY MASS 1 0.0010
141 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
142 VASCULAR OCCLUSION 2 0.0009
143 ASTERIXIS 1 0.0009
144 GASTRIC BYPASS 2 0.0009
145 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
146 HALO VISION 1 0.0009
147 DRUG EFFECT VARIABLE 1 0.0009
148 CHEMICAL BURN 1 0.0009
149 DISTRACTIBILITY 1 0.0009
150 TACHYPHRENIA 3 0.0009
151 IMPLANT SITE INFECTION 2 0.0009
152 INGROWING NAIL 2 0.0008
153 MYOPIA 2 0.0008
154 SLEEP APNOEA SYNDROME 16 0.0008
155 EJECTION FRACTION ABNORMAL 1 0.0008
156 DERMAL CYST 2 0.0008
157 MUSCLE SPASTICITY 10 0.0008
158 DEVICE INFUSION ISSUE 2 0.0008
159 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
160 BLADDER DISCOMFORT 1 0.0008
161 HYPERAESTHESIA TEETH 1 0.0008
162 GASTRIC ULCER PERFORATION 1 0.0008
163 ANGLE CLOSURE GLAUCOMA 2 0.0008
164 CANCER PAIN 2 0.0008
165 OESOPHAGEAL DISORDER 3 0.0008
166 ANAL INCONTINENCE 7 0.0008
167 AORTIC ARTERIOSCLEROSIS 2 0.0008
168 BILIARY OBSTRUCTION 1 0.0008
169 CATHETER SITE PAIN 2 0.0008
170 SPINAL CORD COMPRESSION 3 0.0008
171 ABDOMINAL OPERATION 1 0.0008
172 EPIGASTRIC DISCOMFORT 3 0.0008
173 HYPOVITAMINOSIS 1 0.0008
174 ABNORMAL FAECES 6 0.0007
175 INTESTINAL ISCHAEMIA 4 0.0007
176 THERAPEUTIC RESPONSE DELAYED 2 0.0007
177 ELECTRIC SHOCK SENSATION 2 0.0007
178 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
179 LUNG CANCER METASTATIC 2 0.0007
180 VOMITING PROJECTILE 2 0.0007
181 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
182 GROIN PAIN 6 0.0007
183 ORAL DISORDER 5 0.0007
184 ACUTE ABDOMEN 1 0.0007
185 NECK INJURY 2 0.0007
186 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
187 GENITAL PAIN 1 0.0007
188 GASTROINTESTINAL WALL THICKENING 1 0.0007
189 HYPOSMIA 1 0.0007
190 BONE MARROW DISORDER 2 0.0007
191 VASCULAR DEVICE INFECTION 3 0.0007
192 IRITIS 2 0.0007
193 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
194 BLOOD PRESSURE IMMEASURABLE 1 0.0007
195 ISCHAEMIA 3 0.0007
196 SMALL INTESTINAL OBSTRUCTION 8 0.0006
197 PERFORMANCE STATUS DECREASED 3 0.0006
198 PRE-EXISTING CONDITION IMPROVED 4 0.0006
199 RESPIRATORY RATE DECREASED 2 0.0006
200 GASTROINTESTINAL PAIN 7 0.0006
201 FOREIGN BODY IN THROAT 2 0.0006
202 DRUG SCREEN POSITIVE 5 0.0006
203 PNEUMONIA VIRAL 2 0.0006
204 CYSTITIS INTERSTITIAL 1 0.0006
205 NEAR DEATH EXPERIENCE 2 0.0006
206 MUCOUS STOOLS 3 0.0006
207 BLADDER CANCER STAGE IV 1 0.0006
208 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
209 DRUG TOLERANCE 3 0.0006
210 HANGOVER 2 0.0006
211 DRUG SCREEN NEGATIVE 1 0.0006
212 GLOSSITIS 2 0.0006
213 PRODUCT SUPPLY ISSUE 4 0.0006
214 STRESS FRACTURE 3 0.0006
215 HYPERKERATOSIS 3 0.0005
216 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
217 STREPTOCOCCAL INFECTION 3 0.0005
218 BLADDER SPASM 1 0.0005
219 ADENOCARCINOMA OF COLON 1 0.0005
220 BLOOD IRON INCREASED 1 0.0005
221 HYPERCOAGULATION 1 0.0005
222 CLAVICLE FRACTURE 2 0.0005
223 ADRENAL DISORDER 1 0.0005
224 GINGIVAL DISORDER 2 0.0005
225 CONSTIPATION 113 0.0005
226 THERAPEUTIC PRODUCT EFFECT VARIABLE 2 0.0005
227 PELVIC FRACTURE 4 0.0005
228 WOUND SECRETION 2 0.0005
229 HYPOGEUSIA 1 0.0005
230 PRODUCT USE COMPLAINT 8 0.0005
231 OESOPHAGEAL PAIN 2 0.0005
232 ANORECTAL DISORDER 1 0.0005
233 FOREIGN BODY 2 0.0005
234 DEVICE RELATED SEPSIS 1 0.0005
235 PERIPHERAL VENOUS DISEASE 2 0.0005
236 COMPULSIVE SHOPPING 1 0.0005
237 ILEUS 6 0.0005
238 GASTROINTESTINAL PERFORATION 2 0.0005
239 INTESTINAL STENOSIS 2 0.0005
240 MUSCLE FATIGUE 2 0.0005
241 TONGUE DISCOMFORT 2 0.0005
242 SHOULDER OPERATION 2 0.0005
243 PRODUCT DISPENSING ISSUE 2 0.0005
244 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
245 GASTRIC CANCER STAGE IV 1 0.0005
246 METASTATIC NEOPLASM 2 0.0005
247 POLYP 3 0.0005
248 SOMNAMBULISM 3 0.0005
249 MELANOCYTIC NAEVUS 2 0.0005
250 ABDOMINAL PAIN 106 0.0005
251 INTENTIONAL DEVICE MISUSE 2 0.0005
252 ILEUS PARALYTIC 2 0.0004
253 CALCINOSIS 1 0.0004
254 ADENOCARCINOMA 1 0.0004
255 MENINGITIS ASEPTIC 2 0.0004
256 FEAR OF DEATH 1 0.0004
257 METASTASES TO LYMPH NODES 3 0.0004
258 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
259 DRUG EFFECT INCOMPLETE 16 0.0004
260 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
261 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
262 THERAPY INTERRUPTED 31 0.0004
263 APHTHOUS STOMATITIS 1 0.0004
264 HAEMANGIOMA 1 0.0004
265 BREAKTHROUGH PAIN 1 0.0004
266 MUSCLE TIGHTNESS 7 0.0004
267 PRODUCT DISTRIBUTION ISSUE 4 0.0004
268 FORMICATION 3 0.0004
269 WITHDRAWAL SYNDROME 18 0.0004
270 ESCHERICHIA BACTERAEMIA 1 0.0004
271 HEPATOCELLULAR INJURY 6 0.0004
272 FAECAL INCONTINENCE 2 0.0004
273 APHAGIA 2 0.0004
274 DIABETES INSIPIDUS 1 0.0004
275 HYPERCHOLESTEROLAEMIA 4 0.0004
276 PANCREATIC DISORDER 2 0.0004
277 ABDOMINAL DISTENSION 42 0.0004
278 CATHETER SITE HAEMORRHAGE 1 0.0004
279 FLUID INTAKE REDUCED 2 0.0004
280 AORTIC ANEURYSM 3 0.0004
281 HAEMORRHAGE URINARY TRACT 1 0.0004
282 ILEOSTOMY 1 0.0004
283 ACTINIC KERATOSIS 1 0.0004
284 PERIORBITAL OEDEMA 2 0.0004
285 HERNIA REPAIR 1 0.0004
286 BEDRIDDEN 5 0.0004
287 HALLUCINATION, VISUAL 8 0.0004
288 RENAL CYST 3 0.0004
289 ANORECTAL DISCOMFORT 2 0.0004
290 ANAESTHETIC COMPLICATION 1 0.0004
291 PRODUCT SIZE ISSUE 2 0.0004
292 NEURALGIA 9 0.0004
293 DECUBITUS ULCER 3 0.0004
294 BIPOLAR DISORDER 4 0.0004
295 CLUMSINESS 1 0.0004
296 ASTHENOPIA 2 0.0004
297 INCORRECT ROUTE OF DRUG ADMINISTRATION 13 0.0004
298 TOOTH FRACTURE 4 0.0004
299 INJECTION SITE INJURY 2 0.0004
300 ANAL HAEMORRHAGE 1 0.0004
301 DRUG TOLERANCE DECREASED 1 0.0004
302 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
303 BREAST CANCER STAGE IV 1 0.0004
304 HYPERTONIA 2 0.0003
305 BLOOD MAGNESIUM DECREASED 3 0.0003
306 FIBULA FRACTURE 1 0.0003
307 EYELID MARGIN CRUSTING 1 0.0003
308 NEEDLE ISSUE 10 0.0003
309 GASTROINTESTINAL NECROSIS 1 0.0003
310 SYRINGE ISSUE 6 0.0003
311 HYPOVOLAEMIA 2 0.0003
312 SPINAL OSTEOARTHRITIS 3 0.0003
313 DECREASED INTEREST 2 0.0003
314 PLEURISY 2 0.0003
315 CREPITATIONS 1 0.0003
316 GASTROINTESTINAL INFECTION 3 0.0003
317 SYMPTOM RECURRENCE 2 0.0003
318 DRUG WITHDRAWAL SYNDROME 29 0.0003
319 INGUINAL HERNIA 2 0.0003
320 NO THERAPEUTIC RESPONSE 4 0.0003
321 DYSAESTHESIA 1 0.0003
322 HYPERHIDROSIS 42 0.0003
323 OVARIAN CANCER 3 0.0003
324 MENISCUS INJURY 2 0.0003
325 DEFORMITY 3 0.0003
326 ABDOMINAL ADHESIONS 1 0.0003
327 PRODUCT PACKAGING ISSUE 3 0.0003
328 BLADDER PAIN 1 0.0003
329 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
330 BLOOD POTASSIUM INCREASED 5 0.0003
331 RENAL TUBULAR NECROSIS 3 0.0003
332 TOOTH INFECTION 4 0.0003
333 CHOLECYSTITIS CHRONIC 2 0.0003
334 FEEDING DISORDER 6 0.0003
335 PRODUCT TASTE ABNORMAL 4 0.0003
336 IMPAIRED GASTRIC EMPTYING 4 0.0003
337 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
338 INTESTINAL OBSTRUCTION 11 0.0003
339 TEMPERATURE INTOLERANCE 3 0.0003
340 JOINT EFFUSION 2 0.0003
341 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
342 MULTI-ORGAN FAILURE 5 0.0003
343 DEATH 246 0.0003
344 COLD SWEAT 5 0.0003
345 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
346 CYSTITIS 9 0.0003
347 FLATULENCE 16 0.0003
348 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
349 DIVERTICULUM 2 0.0003
350 RETCHING 6 0.0003
351 BODY HEIGHT DECREASED 3 0.0003
352 FACIAL BONES FRACTURE 1 0.0003
353 ABDOMINAL PAIN UPPER 57 0.0003
354 OSTEOMYELITIS 5 0.0003
355 OESOPHAGITIS 3 0.0003
356 DEVICE KINK 1 0.0003
357 UTERINE LEIOMYOMA 2 0.0003
358 BLOOD PHOSPHORUS DECREASED 1 0.0003
359 CARDIAC DYSFUNCTION 1 0.0003
360 SEDATION 7 0.0003
361 HYDRONEPHROSIS 2 0.0003
362 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
363 CATHETER SITE INFECTION 1 0.0003
364 ACIDOSIS 2 0.0003
365 GASTRIC INFECTION 1 0.0003
366 ACUTE RESPIRATORY FAILURE 5 0.0003
367 CARDIOPULMONARY FAILURE 1 0.0003
368 BASAL CELL CARCINOMA 4 0.0003
369 SEXUAL DYSFUNCTION 3 0.0003
370 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
371 THERAPY CESSATION 13 0.0003
372 CHOLECYSTITIS 3 0.0003
373 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
374 MOVEMENT DISORDER 8 0.0002
375 ENURESIS 1 0.0002
376 HOSPITALISATION 38 0.0002
377 DISCOMFORT 15 0.0002
378 GOITRE 1 0.0002
379 METASTASES TO BONE 4 0.0002
380 APPLICATION SITE EXFOLIATION 1 0.0002
381 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
382 PERITONITIS 5 0.0002
383 EXPIRED PRODUCT ADMINISTERED 8 0.0002
384 HALLUCINATIONS, MIXED 1 0.0002
385 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
386 HYPOPHAGIA 6 0.0002
387 ABSCESS LIMB 1 0.0002
388 HEPATIC PAIN 1 0.0002
389 VITAMIN D DECREASED 2 0.0002
390 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
391 IRRITABLE BOWEL SYNDROME 5 0.0002
392 BLOOD POTASSIUM DECREASED 7 0.0002
393 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
394 PYELONEPHRITIS 2 0.0002
395 URINE OUTPUT DECREASED 2 0.0002
396 GINGIVAL SWELLING 1 0.0002
397 ABDOMINAL ABSCESS 1 0.0002
398 EAR INFECTION 6 0.0002
399 MUSCLE SPASMS 41 0.0002
400 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
401 FREQUENT BOWEL MOVEMENTS 6 0.0002
402 DRUG EFFECT DELAYED 1 0.0002
403 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
404 PRODUCT AVAILABILITY ISSUE 5 0.0002
405 TREATMENT NONCOMPLIANCE 12 0.0002
406 END STAGE RENAL DISEASE 4 0.0002
407 HAEMOGLOBIN INCREASED 1 0.0002
408 DYSPAREUNIA 1 0.0002
409 SHOCK 5 0.0002
410 UROSEPSIS 2 0.0002
411 GRAND MAL CONVULSION 2 0.0002
412 AGRANULOCYTOSIS 4 0.0002
413 THINKING ABNORMAL 4 0.0002
414 MASS 3 0.0002
415 GASTRITIS EROSIVE 1 0.0002
416 DIARRHOEA HAEMORRHAGIC 2 0.0002
417 ARTERIOSCLEROSIS 2 0.0002
418 SPINAL DISORDER 2 0.0002
419 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
420 CHRONIC KIDNEY DISEASE 16 0.0002
421 PRODUCT PRESCRIBING ERROR 5 0.0002
422 ENDOMETRIOSIS 1 0.0002
423 HYPERSOMNIA 6 0.0002
424 SINUS BRADYCARDIA 2 0.0002
425 HERNIA 4 0.0002
426 HYPOKINESIA 3 0.0002
427 GASTROENTERITIS 3 0.0002
428 PARKINSONISM 2 0.0002
429 HAEMORRHOIDS 4 0.0002
430 INFLAMMATORY BOWEL DISEASE 2 0.0002
431 GASTRIC DISORDER 7 0.0002
432 KIDNEY INFECTION 4 0.0002
433 KNEE OPERATION 2 0.0002
434 BREATH SOUNDS ABNORMAL 1 0.0002
435 HYPERVOLAEMIA 1 0.0002
436 DISABILITY 4 0.0002
437 FOOT OPERATION 1 0.0002
438 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
439 PULMONARY MASS 3 0.0002
440 ABDOMINAL TENDERNESS 1 0.0002
441 COLON CANCER 3 0.0002
442 OVARIAN CYST 2 0.0002
443 CYTOKINE RELEASE SYNDROME 4 0.0002
444 EMPHYSEMA 2 0.0002
445 HAEMATEMESIS 5 0.0002
446 DEHYDRATION 26 0.0002
447 RIB FRACTURE 4 0.0002
448 CEREBRAL ISCHAEMIA 1 0.0002
449 FAILURE TO THRIVE 1 0.0002
450 POLLAKIURIA 8 0.0002
451 APLASTIC ANAEMIA 1 0.0002
452 WEIGHT FLUCTUATION 2 0.0002
453 CYANOSIS 3 0.0002
454 FOOD CRAVING 1 0.0002
455 BLOOD LACTIC ACID INCREASED 1 0.0002
456 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
457 COMA 9 0.0002
458 RESPIRATORY TRACT CONGESTION 3 0.0002
459 RENAL PAIN 2 0.0002
460 IMPAIRED WORK ABILITY 4 0.0002
461 COMPRESSION FRACTURE 1 0.0002
462 HEREDITARY ANGIOEDEMA 2 0.0002
463 BACK DISORDER 3 0.0002
464 FAECES DISCOLOURED 4 0.0002
465 SKIN LACERATION 2 0.0002
466 BACK INJURY 2 0.0002
467 SEPTIC SHOCK 8 0.0002
468 PRODUCT PRESCRIBING ISSUE 4 0.0002
469 BLOOD GLUCOSE FLUCTUATION 2 0.0002
470 SKIN LESION 5 0.0002
471 DENTAL CARIES 2 0.0002
472 PLEURAL EFFUSION 11 0.0002
473 GASTRIC ULCER HAEMORRHAGE 1 0.0002
474 DIVERTICULITIS 5 0.0002
475 VENTRICULAR FIBRILLATION 2 0.0002
476 NERVE INJURY 2 0.0002
477 RASH MACULO-PAPULAR 4 0.0002
478 MALNUTRITION 2 0.0002
479 OCULAR DISCOMFORT 2 0.0002
480 CANDIDA INFECTION 3 0.0002
481 EYE INFECTION 2 0.0002
482 MICTURITION URGENCY 2 0.0002
483 CHOLECYSTECTOMY 2 0.0002
484 NEPHROLITHIASIS 8 0.0002
485 EXERCISE TOLERANCE DECREASED 1 0.0002
486 LIVER FUNCTION TEST ABNORMAL 5 0.0002
487 BURNING SENSATION 12 0.0002
488 SPINAL PAIN 2 0.0002
489 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
490 BRADYKINESIA 1 0.0002
491 URINARY INCONTINENCE 5 0.0002
492 GALLBLADDER DISORDER 3 0.0002
493 MIGRAINE 16 0.0002
494 HYPERLIPIDAEMIA 2 0.0002
495 GASTROENTERITIS VIRAL 3 0.0002
496 LACRIMATION INCREASED 5 0.0002
497 ADRENAL INSUFFICIENCY 2 0.0002
498 ILL-DEFINED DISORDER 10 0.0002
499 DERMATITIS ACNEIFORM 1 0.0002
500 VOMITING 77 0.0002
501 GENERALISED OEDEMA 2 0.0002
502 CYST 2 0.0002
503 HEPATIC STEATOSIS 3 0.0002
504 BACTERIAL INFECTION 3 0.0002
505 POISONING 2 0.0002
506 BLOOD SODIUM DECREASED 3 0.0002
507 FOOT FRACTURE 3 0.0002
508 DRUG INEFFECTIVE 208 0.0002
509 WEIGHT DECREASED 44 0.0002
510 FLUID RETENTION 8 0.0002
511 ENTERITIS 1 0.0002
512 POST PROCEDURAL COMPLICATION 3 0.0002
513 OEDEMA PERIPHERAL 19 0.0002
514 HIP FRACTURE 5 0.0002
515 BACK PAIN 36 0.0002
516 RHINORRHOEA 10 0.0002
517 HIATUS HERNIA 2 0.0002
518 APPLICATION SITE VESICLES 1 0.0002
519 ANGINA UNSTABLE 1 0.0002
520 NASAL CONGESTION 9 0.0002
521 INFECTION 22 0.0002
522 ORAL CANDIDIASIS 2 0.0002
523 ANKYLOSING SPONDYLITIS 2 0.0002
524 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
525 PRESCRIBED UNDERDOSE 3 0.0002
526 EYE HAEMORRHAGE 2 0.0001
527 URINARY RETENTION 5 0.0001
528 NEOPLASM MALIGNANT 10 0.0001
529 SPINAL FRACTURE 3 0.0001
530 NAUSEA 118 0.0001
531 PRODUCT USE ISSUE 28 0.0001
532 COLITIS ISCHAEMIC 1 0.0001
533 DYSKINESIA 6 0.0001
534 INJURY ASSOCIATED WITH DEVICE 3 0.0001
535 MOOD ALTERED 4 0.0001
536 CHEST PAIN 27 0.0001
537 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
538 GASTROINTESTINAL DISORDER 13 0.0001
539 HAIR GROWTH ABNORMAL 1 0.0001
540 FEELING COLD 4 0.0001
541 COORDINATION ABNORMAL 2 0.0001
542 EXTRASYSTOLES 1 0.0001
543 WOUND 4 0.0001
544 DEFAECATION URGENCY 1 0.0001
545 KNEE ARTHROPLASTY 3 0.0001
546 BLOOD TEST ABNORMAL 2 0.0001
547 SEASONAL ALLERGY 2 0.0001
548 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
549 HAND FRACTURE 1 0.0001
550 EATING DISORDER 3 0.0001
551 URINARY TRACT INFECTION 24 0.0001
552 INTENTIONAL DOSE OMISSION 4 0.0001
553 PRODUCT QUALITY ISSUE 19 0.0001
554 LIVER FUNCTION TEST INCREASED 3 0.0001
555 PARALYSIS 2 0.0001
556 ANGINA PECTORIS 4 0.0001
557 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
558 HYPOACUSIS 6 0.0001
559 GRAFT VERSUS HOST DISEASE 1 0.0001
560 DERMATITIS BULLOUS 1 0.0001
561 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
562 FEELING ABNORMAL 33 0.0001
563 FAECES SOFT 1 0.0001
564 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
565 ANXIETY 39 0.0001
566 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
567 PAIN 84 0.0001
568 THROMBOSIS 11 0.0001
569 BONE PAIN 8 0.0001
570 ILLNESS 14 0.0001
571 CEREBRAL DISORDER 1 0.0001
572 TACHYCARDIA 12 0.0001
573 FEELING DRUNK 1 0.0001
574 DUODENAL ULCER PERFORATION 1 0.0001
575 ORAL PAIN 3 0.0001
576 RESPIRATORY DISORDER 4 0.0001
577 GENERAL SYMPTOM 1 0.0001
578 IRRITABILITY 8 0.0001
579 HYPOAESTHESIA ORAL 2 0.0001
580 UNEVALUABLE EVENT 10 0.0001
581 DEVICE FAILURE 2 0.0001
582 HAEMODYNAMIC INSTABILITY 1 0.0001
583 ABDOMINAL DISCOMFORT 22 0.0001
584 DRUG DISPENSING ERROR 2 0.0001
585 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
586 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
587 ATRIOVENTRICULAR BLOCK 1 0.0001
588 ANKLE FRACTURE 2 0.0001
589 DECREASED APPETITE 30 0.0001
590 CONCUSSION 1 0.0001
591 APHTHOUS ULCER 1 0.0001
592 LUNG INFECTION 2 0.0001
593 APNOEA 1 0.0001
594 DEVICE MALFUNCTION 9 0.0001
595 HYPOAESTHESIA 19 0.0001
596 HAEMATOCHEZIA 7 0.0001
597 TREMOR 21 0.0001
598 FURUNCLE 1 0.0001
599 ULCER 2 0.0001
600 DIARRHOEA 81 0.0001
601 SCIATICA 2 0.0001
602 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
603 NIGHT SWEATS 4 0.0001
604 MUSCULAR WEAKNESS 14 0.0001
605 ASPHYXIA 1 0.0001
606 HICCUPS 1 0.0001
607 HYPERAESTHESIA 1 0.0001
608 ESCHERICHIA INFECTION 1 0.0001
609 OSTEONECROSIS OF JAW 3 0.0001
610 HEART RATE INCREASED 12 0.0001
611 INSOMNIA 32 0.0001
612 FUNGAL INFECTION 4 0.0001
613 DYSPHONIA 7 0.0001
614 CHILLS 14 0.0001
615 ABDOMINAL PAIN LOWER 3 0.0001
616 FLUSHING 12 0.0001
617 WHEEZING 7 0.0001
618 RENAL FAILURE ACUTE 5 0.0001
619 CONFUSIONAL STATE 19 0.0001
620 CIRCULATORY COLLAPSE 2 0.0001
621 SCAR 2 0.0001
622 INFLUENZA 13 0.0001
623 UNRESPONSIVE TO STIMULI 3 0.0001
624 PARANOIA 2 0.0001
625 DIPLOPIA 3 0.0001
626 RESPIRATORY TRACT INFECTION 3 0.0001
627 ARTHRITIS 9 0.0001
628 GASTRITIS 3 0.0001
629 METASTASES TO LIVER 2 0.0001
630 HYPOXIA 4 0.0001
631 IMMUNOSUPPRESSION 1 0.0001
632 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
633 DRY MOUTH 9 0.0001
634 OEDEMA 6 0.0001
635 TOOTHACHE 2 0.0001
636 LIMB INJURY 3 0.0001
637 PALLOR 3 0.0001
638 GASTROINTESTINAL CARCINOMA 1 0.0001
639 PELVIC PAIN 2 0.0001
640 RESTLESS LEGS SYNDROME 2 0.0001
641 BONE DISORDER 2 0.0001
642 HYPOTENSION 22 0.0001
643 EXOSTOSIS 1 0.0001
644 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
645 RESPIRATORY ARREST 3 0.0001
646 RESPIRATORY DISTRESS 3 0.0001
647 ABNORMAL DREAMS 3 0.0001
648 MENTAL STATUS CHANGES 3 0.0001
649 HAEMOPTYSIS 3 0.0001
650 NECK PAIN 6 0.0001
651 OXYGEN SATURATION DECREASED 6 0.0001
652 FLANK PAIN 1 0.0001
653 TARDIVE DYSKINESIA 3 0.0001
654 HOT FLUSH 8 0.0001
655 COLITIS 4 0.0001
656 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 19 0.0001
657 GASTRIC ULCER 2 0.0001
658 PULMONARY EMBOLISM 10 0.0001
659 PROTEINURIA 2 0.0001
660 FEELING JITTERY 2 0.0001
661 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
662 CHOLESTASIS 2 0.0001
663 SEROTONIN SYNDROME 2 0.0001
664 DRUG PRESCRIBING ERROR 2 0.0001
665 LOWER LIMB FRACTURE 2 0.0001
666 PANCREATIC CARCINOMA 3 0.0001
667 ATELECTASIS 1 0.0001
668 DRUG DOSE OMISSION 17 0.0001
669 DYSSTASIA 3 0.0001
670 AUTOIMMUNE DISORDER 1 0.0001
671 CHOKING 2 0.0001
672 FALL 34 0.0001
673 ASCITES 3 0.0001
674 HEPATOMEGALY 1 0.0001
675 BODY TEMPERATURE DECREASED 1 0.0001
676 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
677 SINUS DISORDER 2 0.0001
678 BLADDER DISORDER 1 0.0001
679 DEVICE ISSUE 9 0.0001
680 SYNCOPE 10 0.0001
681 BRAIN INJURY 1 0.0001
682 CORONARY ARTERY DISEASE 3 0.0001
683 STOMATITIS 6 0.0001
684 HYPOTHERMIA 1 0.0001
685 EXTRA DOSE ADMINISTERED 4 0.0001
686 DEVICE BREAKAGE 4 0.0001
687 DRY THROAT 1 0.0001
688 EPILEPSY 3 0.0001
689 MALAISE 43 0.0001
690 OSTEOPOROSIS 4 0.0001
691 OROPHARYNGEAL PAIN 9 0.0001
692 LIMB DISCOMFORT 3 0.0001
693 CARDIAC ARREST 8 0.0001
694 FEMUR FRACTURE 3 0.0001
695 TOOTH LOSS 2 0.0001
696 SWELLING 9 0.0001
697 PULMONARY HYPERTENSION 2 0.0001
698 AGITATION 7 0.0001
699 SEIZURE 11 0.0001
700 MOUTH ULCERATION 2 0.0001
701 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
702 BRONCHITIS 7 0.0001
703 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
704 HYPOTHYROIDISM 3 0.0001
705 METABOLIC ACIDOSIS 3 0.0001
706 JOINT INJURY 2 0.0001
707 CONTUSION 9 0.0001
708 BREAST CANCER METASTATIC 1 0.0001
709 POOR QUALITY SLEEP 2 0.0001
710 SKIN CANCER 2 0.0001
711 BALANCE DISORDER 8 0.0001
712 HEADACHE 58 0.0001
713 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
714 PRODUCT DISPENSING ERROR 2 0.0001
715 CHOLELITHIASIS 3 0.0001
716 DYSPEPSIA 9 0.0001
717 IMPAIRED HEALING 3 0.0001
718 MELAENA 2 0.0001
719 BLOOD PRESSURE DECREASED 6 0.0001
720 SOMNOLENCE 18 0.0001
721 THROAT IRRITATION 4 0.0001
722 FISTULA 1 0.0001
723 CHROMATURIA 2 0.0001
724 PAIN IN EXTREMITY 26 0.0001
725 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
726 ASTHENIA 33 0.0001
727 LETHARGY 5 0.0001
728 HYPOKALAEMIA 4 0.0001
729 NEOPLASM PROGRESSION 3 0.0001
730 ELECTROLYTE IMBALANCE 1 0.0001
731 FATIGUE 67 0.0001
732 RENAL DISORDER 4 0.0001
733 SURGERY 5 0.0001
734 SLEEP DISORDER 6 0.0001
735 COVID-19 PNEUMONIA 1 0.0001
736 PERIPHERAL SWELLING 13 0.0001
737 OCULAR HYPERAEMIA 4 0.0001
738 BLOOD IRON DECREASED 1 0.0001
739 ATAXIA 1 0.0001
740 NEUROPATHY PERIPHERAL 8 0.0001
741 DISEASE RECURRENCE 4 0.0001
742 PRODUCT ADHESION ISSUE 3 0.0001
743 CATARACT 5 0.0001
744 PRODUCTIVE COUGH 4 0.0001
745 MOBILITY DECREASED 6 0.0001
746 BLOOD PRESSURE FLUCTUATION 2 0.0001
747 LOCALISED INFECTION 2 0.0001
748 BURSITIS 1 0.0001
749 FIBROMYALGIA 2 0.0001
750 UNDERDOSE 6 0.0001
751 DRUG INTERACTION 13 0.0001
752 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
753 INJECTION SITE MASS 3 0.0001
754 ABASIA 2 0.0001
755 SEPSIS 9 0.0001
756 EYE SWELLING 3 0.0001
757 THROMBOCYTOPENIA 9 0.0001
758 APPLICATION SITE IRRITATION 1 0.0001
759 EPISTAXIS 6 0.0001
760 DIZZINESS 40 0.0001
761 DRY EYE 4 0.0001
762 DYSPNOEA EXERTIONAL 3 0.0001
763 ASTHMA 9 0.0001
764 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
765 GASTRIC CANCER 2 0.0001
766 CHEST DISCOMFORT 8 0.0001
767 ADVERSE DRUG REACTION 7 0.0001
768 DYSPNOEA 44 0.0001
769 INFLAMMATION 4 0.0001
770 PNEUMONIA 25 0.0001
771 HAEMATOMA 2 0.0001
772 PLASMA CELL MYELOMA 3 0.0001
773 NERVOUSNESS 4 0.0001
774 DEAFNESS 2 0.0001
775 MUCOSAL INFLAMMATION 2 0.0001
776 MUSCULOSKELETAL PAIN 4 0.0001
777 APPLICATION SITE ERYTHEMA 2 0.0001
778 ANHEDONIA 2 0.0001
779 ABNORMAL BEHAVIOUR 3 0.0001
780 PANCREATITIS 4 0.0001
781 DEPRESSED MOOD 4 0.0001
782 BRADYCARDIA 4 0.0001
783 FEBRILE NEUTROPENIA 5 0.0001
784 CARDIAC DISORDER 7 0.0001
785 INCORRECT DOSE ADMINISTERED 17 0.0001
786 PAIN OF SKIN 2 0.0001
787 DISTURBANCE IN ATTENTION 4 0.0001
788 RASH PRURITIC 4 0.0001
789 ACUTE HEPATIC FAILURE 1 0.0001
790 LUNG NEOPLASM MALIGNANT 3 0.0001
791 APPLICATION SITE RASH 1 0.0001
792 PYREXIA 25 0.0001
793 RHABDOMYOLYSIS 3 0.0001
794 ATRIAL FIBRILLATION 7 0.0001
795 HYPOMAGNESAEMIA 1 0.0001
796 NO ADVERSE EVENT 13 0.0001
797 PANCYTOPENIA 4 0.0001
798 DEVICE OCCLUSION 1 0.0001
799 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
800 HYPONATRAEMIA 4 0.0001
801 EYE PAIN 4 0.0001
802 MYALGIA 12 0.0001
803 NASOPHARYNGITIS 13 0.0001
804 DIALYSIS 1 0.0001
805 LOSS OF CONSCIOUSNESS 9 0.0001
806 CONVULSION 4 0.0001
807 RECTAL HAEMORRHAGE 3 0.0001
808 CARDIOGENIC SHOCK 1 0.0001
809 HERPES ZOSTER 4 0.0001
810 IMPAIRED QUALITY OF LIFE 1 0.0001
811 EYE IRRITATION 4 0.0001
812 PRODUCT SUBSTITUTION ISSUE 4 0.0001
813 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
814 HYPERTHYROIDISM 1 0.0001
815 CONDITION AGGRAVATED 21 0.0001
816 INTENTIONAL PRODUCT MISUSE 6 0.0001
817 SINUSITIS 7 0.0001
818 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
819 RENAL FAILURE 9 0.0001
820 CARDIOMYOPATHY 1 0.0001
821 WEIGHT INCREASED 15 0.0001
822 THERAPY NON-RESPONDER 3 0.0001
823 BONE LOSS 1 0.0001
824 ECONOMIC PROBLEM 1 0.0001
825 BLOOD COUNT ABNORMAL 1 0.0001
826 DEPRESSION 15 0.0001
827 VERTIGO 4 0.0001
828 MEMORY IMPAIRMENT 9 0.0001
829 TINNITUS 3 0.0001
830 HIP ARTHROPLASTY 1 0.0001
831 INJECTION SITE RASH 2 0.0001
832 DEVICE RELATED INFECTION 1 0.0001
833 ARTHRALGIA 27 0.0001
834 VISUAL IMPAIRMENT 8 0.0001
835 EJECTION FRACTION DECREASED 1 0.0001
836 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
837 SWOLLEN TONGUE 2 0.0001
838 BRAIN FOG 1 0.0001
839 PARAESTHESIA 10 0.0001
840 ARRHYTHMIA 3 0.0001
841 DYSPHAGIA 6 0.0001
842 HEAD INJURY 2 0.0001
843 MULTIPLE SCLEROSIS 3 0.0001
844 GAIT DISTURBANCE 12 0.0001
845 COVID-19 11 0.0001
846 BLOOD GLUCOSE DECREASED 3 0.0001
847 HYPOGLYCAEMIA 3 0.0001
848 SWELLING FACE 4 0.0001
849 PRODUCT DOSE OMISSION 4 0.0001
850 BLOOD CREATININE INCREASED 4 0.0001
851 DEVICE DIFFICULT TO USE 4 0.0001
852 DRUG LEVEL INCREASED 1 0.0001
853 VIRAL INFECTION 2 0.0001
854 COAGULOPATHY 1 0.0001
855 SKIN DISORDER 2 0.0001
856 GAIT INABILITY 2 0.0001
857 PALPITATIONS 7 0.0001
858 BLOOD UREA INCREASED 1 0.0001
859 CELLULITIS 3 0.0001
860 EYE PRURITUS 2 0.0001
861 TYPE 2 DIABETES MELLITUS 2 0.0001
862 HYPERSENSITIVITY 11 0.0001
863 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
864 DISEASE PROGRESSION 7 0.0001
865 CEREBROVASCULAR ACCIDENT 10 0.0001
866 BLOOD PRESSURE INCREASED 9 0.0001
867 ACUTE KIDNEY INJURY 9 0.0001
868 OFF LABEL USE 51 0.0001
869 EMOTIONAL DISTRESS 7 0.0001
870 DEVICE DEFECTIVE 1 0.0001
871 ANAEMIA 11 0.0001
872 DELIRIUM 2 0.0001
873 HAEMORRHAGE 6 0.0001
874 ECZEMA 3 0.0001
875 SPEECH DISORDER 3 0.0001
876 HEART RATE DECREASED 2 0.0001
877 HEAD DISCOMFORT 1 0.0001
878 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
879 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
880 DRUG EFFECT DECREASED 3 0.0001
881 INJECTION SITE PAIN 17 0.0001
882 CRYING 2 0.0001
883 C-REACTIVE PROTEIN INCREASED 2 0.0001
884 RESTLESSNESS 2 0.0001
885 DYSURIA 2 0.0001
886 ARTHROPATHY 3 0.0001
887 CONJUNCTIVITIS 1 0.0001
888 BLISTER 3 0.0001
889 HALLUCINATION 4 0.0001
890 HYPOCALCAEMIA 1 0.0001
891 FRACTURE 1 0.0001
892 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
893 ERUCTATION 1 0.0001
894 DYSTONIA 1 0.0001
895 EAR PAIN 1 0.0001
896 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
897 DISORIENTATION 2 0.0001
898 HAEMATOCRIT DECREASED 1 0.0001
899 INJECTION SITE BRUISING 4 0.0001
900 COUGH 14 0.0000
901 SUICIDE ATTEMPT 3 0.0000
902 BLINDNESS 2 0.0000
903 BODY TEMPERATURE INCREASED 1 0.0000
904 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
905 INFLUENZA LIKE ILLNESS 4 0.0000
906 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
907 CARDIO-RESPIRATORY ARREST 2 0.0000
908 ROAD TRAFFIC ACCIDENT 2 0.0000
909 RENAL IMPAIRMENT 4 0.0000
910 OSTEOARTHRITIS 2 0.0000
911 DEEP VEIN THROMBOSIS 3 0.0000
912 AMNESIA 3 0.0000
913 VAGINAL HAEMORRHAGE 2 0.0000
914 DEVICE DISLOCATION 2 0.0000
915 MENTAL DISORDER 2 0.0000
916 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
917 PRODUCT STORAGE ERROR 4 0.0000
918 APPLICATION SITE PAIN 1 0.0000
919 INFUSION RELATED REACTION 3 0.0000
920 LIVER DISORDER 2 0.0000
921 DRY SKIN 6 0.0000
922 GLOSSODYNIA 1 0.0000
923 HEART RATE IRREGULAR 1 0.0000
924 PRURITUS 17 0.0000
925 APPLICATION SITE PRURITUS 1 0.0000
926 HEPATIC ENZYME INCREASED 3 0.0000
927 SKIN IRRITATION 2 0.0000
928 HYPERTENSION 9 0.0000
929 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
930 DIABETIC KETOACIDOSIS 1 0.0000
931 HEPATIC CANCER 1 0.0000
932 RESPIRATORY FAILURE 3 0.0000
933 LUNG DISORDER 2 0.0000
934 ENCEPHALOPATHY 1 0.0000
935 DYSGEUSIA 3 0.0000
936 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
937 LEUKOPENIA 2 0.0000
938 CARDIOVASCULAR DISORDER 1 0.0000
939 HAEMOGLOBIN DECREASED 4 0.0000
940 ERECTILE DYSFUNCTION 1 0.0000
941 ERYTHEMA 8 0.0000
942 EXPOSURE VIA SKIN CONTACT 1 0.0000
943 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
944 CARDIAC FAILURE CONGESTIVE 3 0.0000
945 FEAR 1 0.0000
946 BLOOD GLUCOSE INCREASED 7 0.0000
947 BLOOD BILIRUBIN INCREASED 1 0.0000
948 VISION BLURRED 5 0.0000
949 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
950 URTICARIA 6 0.0000
951 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
952 ACUTE MYOCARDIAL INFARCTION 1 0.0000
953 HEPATIC FAILURE 1 0.0000
954 APHASIA 1 0.0000
955 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
956 FEELING HOT 2 0.0000
957 DRUG ADMINISTRATION ERROR 1 0.0000
958 RASH 14 0.0000
959 BONE DENSITY DECREASED 1 0.0000
960 DRUG INTOLERANCE 3 0.0000
961 EYE DISORDER 1 0.0000
962 HAEMATURIA 1 0.0000
963 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
964 INJURY 2 0.0000
965 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
966 HYPERGLYCAEMIA 1 0.0000
967 ACCIDENTAL OVERDOSE 1 0.0000
968 PRODUCT DOSE OMISSION ISSUE 8 0.0000
969 DYSARTHRIA 1 0.0000
970 INJECTION SITE HAEMORRHAGE 2 0.0000
971 CARDIAC FAILURE 2 0.0000
972 INJECTION SITE ERYTHEMA 3 0.0000
973 DEVICE LEAKAGE 1 0.0000
974 PSORIASIS 3 0.0000
975 COLITIS ULCERATIVE 1 0.0000
976 SUICIDAL IDEATION 2 0.0000
977 ADVERSE EVENT 2 0.0000
978 BLOOD CHOLESTEROL INCREASED 1 0.0000
979 AGGRESSION 1 0.0000
980 PLATELET COUNT DECREASED 2 0.0000
981 DRUG DEPENDENCE 3 0.0000
982 MYOCARDIAL INFARCTION 3 0.0000
983 EXPOSURE DURING PREGNANCY 1 0.0000
984 ALOPECIA 3 0.0000
985 OVERDOSE 3 0.0000
986 ACNE 1 0.0000
987 DIABETES MELLITUS 1 0.0000
988 BREAST CANCER 1 0.0000